Ovid Therapeutics

$3.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-1.93%) Today
-$0.03 (-0.98%) As of 11:38 PM UTC after-hours

Why Robinhood?

You can buy or sell OVID and other stocks, options, and ETFs commission-free!

About OVID

Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY. The listed name for OVID is Ovid Therapeutics Inc. Common Stock.

CEO
Jeremy Max Levin
Employees
59
Headquarters
New York, New York
Founded
2014
Market Cap
224.54M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.89M
High Today
$3.25
Low Today
$3.04
Open Price
$3.12
Volume
1.19M
52 Week High
$9.40
52 Week Low
$1.80

OVID Earnings

-$0.43
-$0.29
-$0.14
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

THCX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure